Loading...
ALXP
ALSPW
Market cap3mUSD
Oct 28, Last price  
0.09EUR
1D
-1.33%
1Q
-34.07%
Jan 2017
-100.00%
IPO
-100.00%
Name

Spineway SA

Chart & performance

D1W1MN
ALXP:ALSPW chart
P/E
—
P/S
0.25
EPS
—
Vol. 1Y
62.20%
Shs. 5Y
—
Rev. 5Y
-0.39%
Div Yld LY
—
Div Yld TTM
—
Revenues
12m
12,430,000
Net income
-2m
-2,238,000
CFO
424k
424,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.

Key people

Stephane Le Roux
Chairman of the Board, Chief Executive Officer
Philippe Laurito
Deputy Chief Executive Officer
David Siegrist
Head of Finance
Frederique Girard-Ory
Member of the Executive Board
Michel Onimus
Member of the Executive Board
IPO date
Feb 08, 2013
Employees
50
Domiciled in
FR
Incorporated in
FR
Headquarters & legal address
7 ALLEE DU MOULIN BERGER
BATIMENT 7
ECULLY 69130
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FY
2025‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT